Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Discontinuation of reducing dose for
Discontinuation syndrome, donepezil
Disinhibition clinical implications mechanism subjective reports benzodiazepines incident rates risk factors
Disruptive mood dysregulation disorder relationship
disulfiram (Antabuse), preventing relapse after alcohol detoxification
Diversion and misuse of prescribed drugs opioids stimulants for ADHD in adults
Donepezil alzheimerâ™s disease treatment for tardive dyskinesia
Dopaminergic agents and dopamine partial agonists, possible effects on impulse control disorders
Dose-related adverse drug effects, increased in hepatic impairment
Differentiating from vascular dementia
Discontinuation symptoms when switching
disruptive mood dysregulation disorder (DMDD), bipolar disorder relationship
Distribution of drugs, changes with old age
Diuretics, lithium interaction
Dose and psychotropic effects of caffeine
Dose tolerability
Dosing Initiation of clozapine in the community Clozapine initiation schedules
Dosing of paliperidone long-acting injection 3-monthly
Dosing regimen for olanzapine
Driving and psychotropic medicines Driving and psychotropic medicines duty of prescriber duty of driver effects of mental illness medication-induced sedation
Dosing and formulations
Dosing recommendations for different routes of ketamine administration and intranasal esketamine in treatment-resistant depression
Driver and Vehicle Licensing Agency (DVLA), UK
Driving impairment
Dronabinol, weight restoration in anorexia nervosa
Drug-drug interactions
Drug-induced excited states Drug-induced excited state identification illicit drugs outcomes restraint risk hyperthermia risk illicit and misused drugs management pathophysiology
Drugs of misuse
Drug treatment for depression.
Drug treatment summary chart